Elite Pharmaceuticals Inc (ELTP)

[lasers]

Pfizer/King/Alpharma have identical Patent Applications describing the "single unit" manufacturing for:

(1) ALO-01 Morphine agonist Naltrexone antagonist


http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=1&p=1&f=G&l=50&d=PG01&S1=%22ALO-01%22&OS=%22ALO-01%22&RS=%22ALO-01%22

Pharmaceutical Compositions


Abstract
Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a "single unit", and wherein the seal coat forms a layer physically separating the antagonist from the agonist from one another. Methods for manufacturing such a pharmaceutical composition are also provided.




(2)ALO-02 Oxycodone agonist Naltrexone antagonist

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=1&f=G&l=50&d=PG01&p=1&S1=%22ALO-02%22&OS=%22ALO-02%22&RS=%22ALO-02%22

PHARMACEUTICAL COMPOSITIONS


Abstract
Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a "single unit", and wherein the seal coat forms a layer physically separating the antagonist from the agonist from one another. Methods for manufacturing such a pharmaceutical composition are also provided. Methods for treating pain using such compositions is also demonstrated.

####

Until Pfizer/King/Alpharma solves the stability problem for the "single unit" manufacturing for ALO-01 Morphine agonist Naltrexone antagonist it remains on recall.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=75773218

The same stability problems will apply for the "single unit" manufacturing for ALO-02 Oxycodone agonist Naltrexone antagonist.